Angiolab, Inc. (XKON:251280)
2,365.00
-25.00 (-1.05%)
At close: Mar 9, 2026
Angiolab Market Cap
Angiolab has a market cap or net worth of 8.26 billion as of March 9, 2026. Its market cap has decreased by -63.12% in one year.
Market Cap
8.26B
Enterprise Value
n/a
Revenue
702.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,365.00
Market Cap Chart
Since April 5, 2017, Angiolab's market cap has decreased from 8.46B to 8.26B, a decrease of -2.39%. That is a compound annual growth rate of -0.27%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OLIPASS | 8.40B |
| Femtobiomed | 6.82B |
| Genotech | 6.15B |
| The Technology | 4.72B |
| Plumbline Life Sciences | 18.69B |
| Moogene Medi | 20.15B |
| MOA Life Plus | 27.14B |
| ADBiotech | 29.72B |